A carregar...
The Case for Low Blood Pressure Targets
The “totality” of hypertension clinical trial endpoint data has shown that the absolute benefit of pharmacological blood pressure (BP) lowering is directly related to the BP level and baseline cardiovascular risk, albeit with attenuation of the relative risk reduction per unit of BP lowering in pati...
Na minha lista:
| Publicado no: | Am J Hypertens |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5155566/ https://ncbi.nlm.nih.gov/pubmed/27572960 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ajh/hpw087 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|